The Novartis Foundation has appointed Prof. Dr. Jo Ivey Boufford, a well-known expert in urban health and disease prevention, to its Board of Trustees, effective immediately.
Prof. Boufford is a Clinical Professor of Global Public Health at New York University, the current President of the International Society for Urban Health and the Immediate Past President at the New York Academy of Medicine. She has worked in leadership positions for numerous organizations spanning the US federal government, the World Health Organization, the International Women's Health Coalition, and the National Academy of Medicine. At NYU, Dr. Boufford is also Emeritus Professor of Public Service, Health Policy and Management and Dean of the Robert F. Wagner Graduate School of Public Service and she is a Clinical Professor of Pediatrics at the NYU Medical School.
“I am delighted to have Prof. Jo Boufford join us on the Board,” says Dr. Ann Aerts, Head of the Novartis Foundation. “Prof. Boufford brings with her a wealth of experience across medicine, international affairs, health policy and public administration and has been relentless in advocating patient-centered advocacy and the need for attention to prevention through action on the broad determinants of health in communities. In particular, Jo’s background in urban health is of great relevance for our Better Hearts Better Cities initiative.”
“I am excited to be joining the team at the Novartis Foundation and share their commitment to designing scalable urban health solutions with patients and communities at the center,” says Prof. Jo Ivey Boufford. “Disparities in access to healthcare are a global challenge and we must find innovative ways to prevent the growing burden of noncommunicable diseases , especially in cities, that limit our ability to achieve global health goals.”
Alongside Prof. Jo Ivey Boufford, members of the Novartis Foundation’s Board of Trustees are Novartis Chairman Dr. Joerg Reinhardt, Dr. Ann Aerts, Head of the Novartis Foundation, Dr. Patrice Matchaba, Global Head of Global Health and Corporate Responsibility at Novartis, Dr. Vas Narasimhan, Chief Executive Officer of Novartis, and Prof. Peter Piot, Director of the London School of Hygiene & Tropical Medicine.